Advanced

AJNR - American Journal of Neuroradiology

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Aviv, R. I. Articles by Colquhoun, I. R. Search for Related Content PubMed PubMed Citation Articles by Aviv, R. I. Articles by Colquhoun, I. R.

American Journal of Neuroradiology 26:1744-1750, August 2005
© 2005 American Society of Neuroradiology

INTERVENTIONAL

Abciximab in Patients with Ruptured Intracranial Aneurysms

Richard I. Aviv^a, Richard O’Neill^b, Maneesh C. Patel^b and Iain R. Colquhoun^b

^a Neuroradiology Section, Imaging Department, Charing Cross Hospital, London, United Kingdom
^b Division of Neuroradiology, Department of Radiology, Sunnybrook Hospital, Toronto, Ontario, Canada

Address reprint requests to Dr. Richard Aviv, Division of Neuroradiology, Department of Radiology, Sunnybrook & Women’s College Health Sciences Centre, 2075 Bayview Avenue, Toronto ON M4N 3M5

BACKGROUND AND PURPOSE: Experience with intravenous abciximab to manage thromboembolism during treatment of ruptured intracranial aneurysms is limited. We present our experience in 13 patients.

METHODS: We retrospectively reviewed all patients with thromboembolic complications during endovascular management of ruptured intracranial aneurysms. Thromboembolic complications were treated with intravenous abciximab. We recorded patient and aneurysm demographics, aneurysm occlusion, drug therapy, complications, and outcomes.

RESULTS: World Federation of Neurological Surgeons Grades were 1 or 2 in 11 patients (85%). Median time from diagnostic angiography to treatment was 1 day. Ten (77%) aneurysms involved the anterior or posterior communicating artery, and one each occurred in the posterior inferior cerebellar artery, middle cerebral artery, and basilar regions. Eleven aneurysms were <10 mm. Five were incompletely occluded (0%–90% treated) at the time of the complication. Thromboembolic complications were at the coil-ball/parent-artery interface in nine patients (69%). Two were associated with coil-loop prolapse; one was prophylactically treated without evidence of thromboembolism. Five patients (38%) had distal complications; one also had a proximal thrombus. All patients received an intravenous bolus of abciximab (5–10 mg in 92%) without infusion. Postprocedural recanalization was complete in eight (62%) and partial in four (31%). Eleven patients (85%) had a Glasgow Outcome Scale score of 1 at 3 months. One had a poor outcome (GOS4). One died following additional coiling after abciximab administration, though this intervention was uneventful in three others.

CONCLUSION: Abciximab completely or partially treated thromboembolic complications arising during coiling of ruptured aneurysms. Further coiling should be performed with extreme caution and needs to be decided on a patient-by-patient basis.

This article has been cited by other articles:

				K.F. Layton, H.J. Cloft, L.A. Gray, D.A. Lewis, and D.F. Kallmes Balloon-Assisted Coiling of Intracranial Aneurysms: Evaluation of Local Thrombus Formation and Symptomatic Thromboembolic Complications AJNR Am. J. Neuroradiol., June 1, 2007; 28(6): 1172 - 1175. [Abstract] [Full Text] [PDF]

				W.J. van Rooij, M. Sluzewski, G.N. Beute, and P.C. Nijssen Procedural Complications of Coiling of Ruptured Intracranial Aneurysms: Incidence and Risk Factors in a Consecutive Series of 681 Patients AJNR Am. J. Neuroradiol., August 1, 2006; 27(7): 1498 - 1501. [Abstract] [Full Text] [PDF]

				P. Blom, M. Korona, L. Haikal, and R. Aviv Platelet Receptors AJNR Am. J. Neuroradiol., January 1, 2006; 27(1): 8 - 9. [Full Text] [PDF]